Coronado Research Appoints Dr. Jennifer Bradford as VP and Head of Data Science

Coronado Research Welcomes Dr. Jennifer Bradford

Coronado Research, a consultancy known for its innovative approach in the pharmaceutical field, has officially announced the appointment of Dr. Jennifer Bradford as the Vice President and Head of Data Science. This strategic move is aimed at furthering the company's mission to leverage data and technology in optimizing clinical development processes.

Background of Dr. Jennifer Bradford

Dr. Jennifer Bradford brings a wealth of experience with a robust background in both academia and the pharmaceutical industry. Her career is distinguished by a proven track record in leading the development and integration of customer-focused digital solutions. This includes extensive work in artificial intelligence (AI) and data science, where she has demonstrated her ability to drive scientific advancement through innovative technologies.

Having managed cross-functional teams and collaborated closely with various stakeholders, Dr. Bradford has effectively maximized the utility of data within her previous roles. Her adeptness at connecting digital innovations with clinical applications places her in a unique position to enhance Coronado Research's capabilities.

Insights from Leadership

Professor Jennifer Visser-Rogers, Chief Scientific Officer at Coronado Research, expressed enthusiasm about the appointment, stating, "Jenny brings a wealth of experience in data science and is an expert in leveraging AI to extract value from data. Her leadership will play a pivotal role in our vision to advance pharmaceutical research through data-driven clinical trials and emerging technologies."

Dr. Bradford herself commented on the challenges many companies face when trying to integrate digital solutions into drug development. She remarked, "While it's well recognized that technology can transform drug development, many organizations struggle with how to implement these solutions effectively. At Coronado Research, we are eager to support companies in unlocking the full potential of AI and other digital tools."

A Broader Vision for Data-Driven Solutions

In her new role, Dr. Bradford is set to work across various functions within Coronado Research. The goal is to provide clients with comprehensive access to data-driven strategies, advanced analytics, and AI capabilities throughout the entire drug development process. Her approach will emphasize collaboration, ensuring that technology not only enhances scientific inquiry but also aligns with market needs and healthcare objectives.

What’s Next for Coronado Research?

As a consultancy-led organization, Coronado Research aims to support pharmaceutical, biotechnology, and medical device companies by streamlining clinical development processes. By harnessing AI, machine learning, and an array of cutting-edge technologies, they aspire to 'join the dots' between regulatory strategy, advanced analytics, market access, and health economics. This holistic approach is designed to ensure that new treatments are developed with a significant understanding of both scientific and market landscapes.

Whether you are a stakeholder in the pharmaceutical industry or a keen observer of technological advancements in healthcare, the appointment of Dr. Jennifer Bradford marks a pivotal moment for Coronado Research. Her expertise is expected to greatly influence the data science landscape within the organization and beyond.